Blood pressure medication recalled nationwide. See affected drug
A nationwide medication recall affects thousands of blood pressure pill bottles following failed quality tests.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
The FDA issued a nationwide Class II recall for blood pressure medication due to dissolution and quality issues. Inventia Healthcare recalled thousands of bottles of chlorthalidone tablets, marking a second recall for the drug in three months.
Epilogue added 42d ago, after coverage quieted.
The brief
According to reports from outlets such as the New York Post, Fast Company, Newser, Democrat and Chronicle, qz.com, NBC 5 Dallas-Fort Worth, kens5.com, Black Doctor, wcnc.com, and wbbjtv.com, the product action was triggered by specific quality concerns. Specific figures regarding the affected products vary across the reporting. Some reports specify that 13,000 bottles are involved in the recall, while other coverage points to over 25,000 bottles of chlorthalidone tablets.
According to the reporting, the medication was recalled nationwide after failing FDA dissolution testing and encountering related quality issues. The manufacturer involved in the recall is identified in the coverage as Inventia Healthcare. The reports emphasize what consumers need to look out for, providing details on why the medication failed standard evaluations and prompting alerts regarding the affected drug.
As the situation develops, coverage does not yet specify long-term consequences for the manufacturer or additional regulatory actions. Readers and patients are advised by the reporting to look out for further announcements and verify specific details regarding the recalled medication.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (89% supported) Updated 44d ago.
Quick answers
Which company is recalling the blood pressure medication?
According to coverage from qz.com, Inventia Healthcare is recalling the medication.
Why was the medication recalled?
Reports from kens5.com and wcnc.com state the medication was recalled after failing FDA dissolution testing and quality issues.
How many bottles are affected by the recall?
Coverage varies on the exact count, with some reports citing 13,000 bottles and others citing more than 25,000 bottles of chlorthalidone tablets.
Coverage (16)
- Blood pressure medication recalled nationwide under FDA’s Class II risk level WPRI.com · 44d ago
- FDA recalls 25k bottles of blood pressure meds for these products Bergen Record · 44d ago
- Blood pressure medication recalled over dissolving issue audacy.com · 44d ago
- Nationwide Recall Issued For Popular Blood Pressure Medication 97.3 KKRC · 44d ago
- FDA Recalls and Warnings: Blood Pressure Drug Recalled for Second Time in 3 Months; Some GLP-1 Pens May Contain No Medication MedShadow Foundation · 44d ago
- FDA recalls thousands more bottles of blood pressure medication due to quality issue NBC 5 Chicago · 44d ago
- Popular blood pressure drug recalled over dissolution issues New York Post · 44d ago
- 13,000 bottles of blood pressure medication are being recalled nationwide: What to look out for Fast Company · 44d ago
- Blood Pressure Drug Recalled Nationwide Newser · 44d ago
- Blood pressure medication recalled over dissolution issue. What to know Democrat and Chronicle · 44d ago
- Inventia Healthcare recalls 25,000 bottles of chlorthalidone tablets qz.com · 45d ago
- FDA recalls more than 13k bottles of blood pressure medication after quality issue NBC 5 Dallas-Fort Worth · 45d ago
- Blood pressure medication recalled nationwide after failing FDA dissolution testing kens5.com · 45d ago
- ALERT: Nationwide Recall of Blood Pressure Medication; 13,000+ Bottles Black Doctor · 45d ago
- Blood pressure medication recalled nationwide after failing FDA dissolution testing wcnc.com · 45d ago
- More than 25,000 bottles of blood pressure medication recalled. Here’s why wbbjtv.com · 45d ago
Topics
Related trends
EXCLUSIVE: US FDA shelves commissioner's voucher program for speedy drug reviews, sources say
The US FDA has shelved its commissioner's priority review voucher pilot program for expedited drug reviews, according to exclusive reporting from Reuters and coverage across multiple outlets.
Christina Applegate fears that ‘poisoning’ may be behind her misdiagnosis of MS
Christina Applegate reveals she is investigating whether breast implant illness caused her multiple sclerosis misdiagnosis, calling it potential 'poisoning.'
FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
Federal regulators mandate new vision loss warning labels across the widely used GLP-1 receptor agonist drug class.
FDA tells GLP-1 makers to warn of potential vision loss side effect
The FDA is requiring all GLP-1 drug makers to add warnings about a possible increased risk of NAION, a rare eye condition that can cause sudden and permanent vision loss.
FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
Federal regulators issue a new warning regarding GLP-1 medications and a rare eye condition linked to sudden blindness.
US regulator orders makers of weight-loss drugs to carry blindness risk warning
The FDA is requiring all GLP-1 drug makers to add a warning about NAION, a rare eye condition that can cause sudden blindness, to their prescribing information.